603392.SS
603392.SS
CNE100004090
BEIJING WANTAI BIOLOGICAL PHARM
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
34.09B EUR
34.1B EUR
50.26B EUR
56.82B EUR
Enterprise Value
30.28B EUR
32.05B EUR
48.26B EUR
54.74B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
47.3x
--
--
--
Price to Sales
16.84x
24.91x
39.06x
48.81x
Price to Book
2.9x
2.91x
4.25x
4.79x
EV/Revenue
14.96x
23.41x
37.5x
47.02x
EV/EBITDA
-76.75x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.89%
-1.35%
-1.5%
-1.17%
ende